Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201102195867N1Phase 2Completed
Phase 2, randomised trial of pioglitazone and drospirenone + ethinyl estradiol in endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Symptoms of endometriosis and Stage of endometriosis. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201102195867N1.